Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

26 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Estring Articles

Schering-Plough finally back in profit after Organon buy; exceeds expectations, pleasing shareholders

9 February 2009

S-P profit falls 21%, still up on predictions

27 October 2008

S-P profit down again on Organon charges

28 July 2008

UPDATE: S-P profit down, sales up on Organon buy

5 May 2008

Akzo Nobel's 2006 net income increases 20%

26 February 2007

Organon's NuvaRing approved in Australia

17 July 2006

Pharmacia & Paladin sign Canadian distribution deal

28 January 2002

Pharmacia Canada has named Paladin Labs as the exclusive Canadian distributorhyperprolactinemia, Estring (estradiol vagi

28 January 2002

USA Approves Estring

6 May 1996

Pharmacia & Upjohn's Estring approvable...

27 November 1995

Marriage Of Pharmacia And Upjohn Will Create New $13 Bill Drug Group

4 September 1995

Estring Launch

14 November 1994

KABI PHARMACIA AND LEIRAS JV

5 July 1993

Showing 1-13 of 13 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS